Patents by Inventor Liang Deng

Liang Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150238624
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: December 23, 2014
    Publication date: August 27, 2015
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Publication number: 20150235634
    Abstract: Techniques are disclosed relating to asymmetric circuits. In some embodiments, a storage element is configured to maintain a first input value as an input to an asymmetric circuit during a time interval. For example, in one embodiment, the time interval may correspond to a frame of video data and the storage element may be configured to store a filter coefficient for the frame of video data. In some embodiments, the storage element may be configured to store the value as a constant for multiple operations by the asymmetric circuit. In some embodiments, the asymmetric circuit is configured to generate a plurality of output values based on the first input value and respective ones of a set of second input values. In some embodiments, the asymmetric circuit is leakage power asymmetric and/or critical path asymmetric. This may increase performance and/or reduce power consumption.
    Type: Application
    Filed: February 18, 2014
    Publication date: August 20, 2015
    Applicant: Apple Inc.
    Inventors: Michael L. Liu, Liang Deng
  • Patent number: 9095621
    Abstract: The invention provides oligomer-bis-chromonyl compound conjugates. The conjugates of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: August 4, 2015
    Assignee: NEKTAR THERAPEUTICS
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Patent number: 9090535
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: July 28, 2015
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Hema Gursahani
  • Publication number: 20150157734
    Abstract: The invention provides oligomer-bis-chromonyl compound conjugates. The conjugates of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
    Type: Application
    Filed: February 20, 2015
    Publication date: June 11, 2015
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Publication number: 20150112069
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Publication number: 20150070360
    Abstract: Disclosed is a method and mobile terminal for drawing sliding track. The method comprises: A) obtaining the total sliding distance and the total sliding time for sliding from the sliding start position to the sliding end position; B) drawing the sliding track of the current frame image in the sliding start position, recording the current time for finishing the drawing of the current frame image; C) obtaining the drawing time from the drawing start time to the current time for finishing the drawing of the current frame image, judging whether the drawing time is greater than or equal to the total sliding time, if no, performing the step D, if yes, performing the step E; D) according to the drawing time, the total sliding time and the total sliding distance, obtaining the current sliding distance, replacing the sliding start position by the sum of the sliding start position and the current sliding distance, returning to the step B; E) drawing the sliding track of the last frame image in the sliding end position.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 12, 2015
    Inventors: Zhiyun Liu, Guoxiong Lin, Liang Deng, Gen Luo, Maoqing Fu
  • Publication number: 20150065706
    Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: October 30, 2014
    Publication date: March 5, 2015
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Patent number: 8952032
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: February 10, 2015
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Patent number: 8946285
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: February 3, 2015
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Publication number: 20140366114
    Abstract: A login method and device, and a terminal and a network server are disclosed, which relate to communications technologies. In the method, acquire an account waiting for login and a first password, and judge whether the first password is the same as a local password bound with the pre-stored account. If the first password is the same as the local password bound with the pre-stored account, upload a second password corresponding to the pre-stored account to a network server for matching, and log in to the account once the second password is successfully matched. The present invention introduces a custom password (i.e., the first password), thus avoids the complexity to enter an actual login password (i.e., the second password) and the unsafety to remember the actual login password in a terminal, and enhances the convenience and safety for login and offers greater user experience.
    Type: Application
    Filed: August 21, 2014
    Publication date: December 11, 2014
    Inventors: Jiao Wang, Ling Liu, Liang Deng, Yibo Sun
  • Patent number: 8895553
    Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: November 25, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Publication number: 20140323529
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.
    Type: Application
    Filed: April 30, 2014
    Publication date: October 30, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Zhongxu Ren, Bo-Liang Deng, Jennifer Riggs-Sauthier, Micah Harvey
  • Publication number: 20140288295
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.
    Type: Application
    Filed: June 6, 2014
    Publication date: September 25, 2014
    Inventors: Bo-Liang Deng, Timothy A. Riley, Jennifer Riggs-Sauthier
  • Publication number: 20140256732
    Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: May 20, 2014
    Publication date: September 11, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Publication number: 20140256310
    Abstract: A method and an apparatus provide network problem location based on subscriber perception. A server firstly receives and parses a call history record CHR log sent by a network management system, then determines, according to a parsing result, whether a call of a subscriber is a key quality indicator KQI exception event, and locates a location and a cause of the KQI exception event. The technical solutions provided in the present invention are capable of finding a network problem and locating the network problem from the perspective of subscriber perception.
    Type: Application
    Filed: May 23, 2014
    Publication date: September 11, 2014
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Xiufeng WANG, Zhenglei XU, Xin CHEN, Liang DENG
  • Publication number: 20140200235
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: September 20, 2013
    Publication date: July 17, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer RIGGS-SAUTHIER, Bo-Liang Deng, Timothy A. Riley
  • Patent number: 8778898
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: July 15, 2014
    Assignee: Nektar Therapeutics
    Inventors: Bo-Liang Deng, Timothy A. Riley, Jennifer Riggs-Sauthier
  • Patent number: 8772479
    Abstract: The invention relates to (among other things) oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: July 8, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Publication number: 20140187790
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: September 20, 2013
    Publication date: July 3, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer RIGGS-SAUTHIER, Bo-Liang DENG, Timothy A. RILEY